The ophthalmic devices market would grow at a CAGR of 3.19% over the predicted time frame. The market is expected to increase in value from US$ 69.99 Bn in 2022 to US$ 78.4 Bn in 2030.

The on ophthalmic devices Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2241

Report Scope of the Ophthalmic Devices Market

A recent report provides crucial insights along with application based and Forecast information in the Global Ophthalmic devices Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Ophthalmic devices market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Ophthalmic devices market are included as given below:

Ophthalmic devices Market Key Players

• Novartis AG
• Carl Zeiss Meditec AG
• Essilor International S.A.
• Nidek Co., Ltd.
• Topcon Corporation
• Valeant Pharmaceuticals International, Inc.
• Ziemer Ophthalmic Systems AG
• Hoya Corporation
• HAAG-Streit Holding AG
• Johnson & Johnson

Market Segments

By Product

• Vision Care Products
  • Spectacles
  • Contact lenses
    • Soft contact lenses
    • Rigid gas permeable lenses
    • Hybrid contact lenses
• Surgical devices
  • Cataract surgical devices
    • Intraocular lenses
    • Ophthalmic Viscoelastic devices
    • Phacoemulsification devices
    • Cataract surgical lasers
    • IOL Injectors
• Vitreoretinal surgical devices
  • Vitrectomy machines
  • Vitreoretinal packs
  • Photocoagulation lasers
  • Illumination devices
  • Vitrectomy probes
• Refractive surgical devices
  • Femtosecond lasers
  • Excimer lasers
  • Others
• Glaucoma surgical devices
  • Glaucoma drainage devices
  • Microinvasive glaucoma surgery devices
  • Glaucoma laser systems
• Ophthalmic microscopes
• Ophthalmic surgical accessories
  • Surgical instruments & kits
  • Ophthalmic forceps
  • Ophthalmic spatulas
  • Ophthalmic tips & handles
  • Ophthalmic scissors
  • Macular lenses
  • Ophthalmic cannulas
  • Others
• Diagnostic and monitoring devices
  • Optical Coherence Tomography Scanners
  • Fundus Cameras
  • Perimeters/Visual Field Analyzers
  • Autorefractors & Keratometers
  • Ophthalmic Ultrasound Imaging Systems
    • A-scan ultrasound imaging systems
    • B-scan ultrasound imaging systems
    • Ultrasound microscopes
    • Pachymeters
  • Tonometers
  • Slit Lamps
  • Phoropters
  • Wavefront Abberometers
  • Optical Biometry Systems
  • Ophthalmoscopes
  • Lensmeters
  • Corneal Topography Systems
  • Chart Projectors
  • Specular Microscopes
  • Retinoscopes

By End User

• Hospitals & Eye Clinics
• Academic & Research Laboratories
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Report Objectives

• To define, describe, and forecast the global ophthalmic devices market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the ophthalmic devices market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Ophthalmic Devices Market 

5.1. COVID-19 Landscape: Ophthalmic Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Ophthalmic Devices Market, By Product

8.1. Ophthalmic Devices Market, by Product, 2022-2030

8.1.1. Vision Care Products

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Surgical devices

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Vitreoretinal surgical devices

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Refractive surgical devices

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Glaucoma surgical devices

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Ophthalmic microscopes

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Ophthalmic surgical accessories

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Diagnostic and monitoring devices

8.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Ophthalmic Devices Market, By End User

9.1. Ophthalmic Devices Market, by End User, 2022-2030

9.1.1. Hospitals & Eye Clinics

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Academic & Research Laboratories

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Ophthalmic Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.2. Market Revenue and Forecast, by End User (2017-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.4.2. Market Revenue and Forecast, by End User (2017-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.2. Market Revenue and Forecast, by End User (2017-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.4.2. Market Revenue and Forecast, by End User (2017-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.5.2. Market Revenue and Forecast, by End User (2017-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.6.2. Market Revenue and Forecast, by End User (2017-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.4.2. Market Revenue and Forecast, by End User (2017-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.5.2. Market Revenue and Forecast, by End User (2017-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.6.2. Market Revenue and Forecast, by End User (2017-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.2. Market Revenue and Forecast, by End User (2017-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.4.2. Market Revenue and Forecast, by End User (2017-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.5.2. Market Revenue and Forecast, by End User (2017-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.6.2. Market Revenue and Forecast, by End User (2017-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.2. Market Revenue and Forecast, by End User (2017-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.4.2. Market Revenue and Forecast, by End User (2017-2030)

Chapter 11. Company Profiles

11.1. Novartis AG

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Carl Zeiss Meditec AG

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Essilor International S.A.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Nidek Co., Ltd.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Topcon Corporation

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Topcon Corporation

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Ziemer Ophthalmic Systems AG

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Hoya Corporation

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. HAAG-Streit Holding AG

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Johnson & Johnson

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: [email protected]

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com